(Note: Gores Holdings X, Inc. withdrew its plans for its SPAC IPO in an SEC filing dated Oct. 13, 2022. The blank check company had filed its S-1 in December 2021.)  We intend to capitalize on the ability of our management team to identify, acquire and manage a business that can benefit from our operational […]

(Note: Rue Gilt Groupe, Inc. withdrew its IPO plans in an SEC letter dated Oct. 13, 2022. The company filed its S-1 in November 2021, but it never updated the filing to disclose IPO terms. Rue Gilt Groupe, Inc. submitted confidential IPO documents on Aug. 20, 2021.)   Our mission is to provide the most […]

Note: This is a NASDAQ uplisting from the OTC. This is NOT an IPO. We are a provider of consumer health care, beauty, and lifestyle products. (Incorporated in Nevada) Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically tested brain health supplement (this study was performed independently and is not related to any FDA-approved investigational […]

(Note: Henley Park Acquisition Corp. withdrew its plans for its SPAC IPO in an SEC letter dated Oct. 20, 2022. The proposed IPO had called for 17.5 million units at $10.00 each to raise $175. million. Each unit had consisted of one share of common stock and three-fourths of one redeemable warrant, according to the […]

(Note: Milan Laser Inc. withdrew its IPO plans in an SEC letter dated Oct. 21, 2022. Milan Laser had not disclosed terms for its IPO. The company filed its S-1 on Oct. 15, 2021, after submitting confidential IPO documents on Aug. 12, 2021.) Co-founded in 2012 by Dr. Shikhar Saxena and Dr. Abe Schumacher, we are revolutionizing […]

PishPosh is a rapidly growing online retailer of premium baby products, specifically luxury strollers ($200 to $300 and up), car seats and other baby gear, including chairs and feeding items. We focus on offering baby gear for the mid- to higher income demographics, specifically those with an annual income of $75,000 and more. Currently, our average […]

  We use artificial intelligence and machine learning to advance medicines for both internal and external projects. We are committed to increasing the probability of success and decreasing the time and cost involved in developing therapeutics. Most current AI/ML platforms still fall short in their ability to synthesize disparate, high-dimensional data for actionable insight. Our platform […]

We are a B2B fintech (FinTech) marketplace connecting commercial property borrowers and lenders with a human touch. We seek to revolutionize the commercial real estate lending market by making it hyper-efficient, transparent, and accessible to all rather than the few. (Incorporated in Delaware) **Note: We do not make loans or share risks. **Note: Our business model includes earning […]

(Note: Acrivon Therapeutics priced its IPO on Monday night, Nov. 14, 2022, at $12.50 – far below its price range of $16 to $18 – and priced 7.55 million shares (7,550,000 shares) to raise $94.38 million. Acrivon Therapeutics filed a Free Writing Prospectus on Monday night, Nov. 14, 2022, that showed only three names – […]

(Note: Snail, Inc. priced its IPO on Nov. 9, 2022, at $5.00 a share on 3.0 million shares – in line with the terms in its revised prospectus – to raise $15.0 million.) We are a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world. (Incorporated in Delaware)   […]